Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 18
CMOs Entered in Texas Litigation to Guide 'Significant Number' of Cases
Distributor Defendants Challenge California Master Vioxx Complaint
Plaintiff Moves to Exclude Evidence of Merck's 'Naproxen Theory'
Merck Moves to Exclude Causation Testimony Ahead of First Federal Vioxx Trial
Notice Indicates that California State Celebrex, Bextra Claims Will be Severed
Plaintiff Wants Opinions on 18-Month Vioxx Injury Threshold Excluded
Judge Applies Michigan Law to Dismiss Pennsylvania Bextra Case
Judge Remands Celebrex Stroke Case, Allows Joinder of Sales Representative
